Found 2 clinical trials
PB2452 in Ticagrelor-treated Patients With Uncontrolled Major or Life-Threatening Bleeding or Requiring Urgent Surgery or Invasive Procedure
Approximately 200 patients will be enrolled at approximately 200 centers worldwide. Patients with reported use of ticagrelor within the prior 5 days who require urgent ticagrelor reversal will be eligible for enrollment. These populations will be enrolled based on separate inclusion criteria.
- 0 views
- 16 Feb, 2024
- 6 locations
FAPI Imaging Predicts Adverse Cardiac Events in Chronic Total Occlusion (FACT-2)
Inclusion CriteriaAge ≥ 18 yearsPresence of at least one untreated chronic total occlusion (CTO) lesion in a major coronary artery (diameter ≥ 2.5 mm, TIMI 0 flow for ≥ 3 months) confirmed by coronary angiography or CTCAPatient eligible for PCI and undergoing FAPI PET/CT imaging prior to interventionWritten informed consent …
- 0 views
- 16 Jun, 2025